Literature DB >> 15683525

Serial changes in right ventricular apical pacing lead impedance predict changes in left ventricular ejection fraction and functional class in heart failure patients.

Bruce S Stambler1, Kenneth A Ellenbogen, Zhe Liu, Paul Levine, Thomas R Porter, Xiaozheng Zhang.   

Abstract

Pacing impedance has been proposed to monitor the clinical status of patients with congestive heart failure (CHF). This study examined whether changes in right ventricular (RV) pacing impedance correlate with changes in left ventricular ejection fraction (LVEF) and New York Heart Association (NYHA) functional class during long-term follow-up in pacemaker recipients with CHF. The study included 67 patients, 70 +/- 12 years of age, in NYHA class II or III, and with a mean LVEF = 29 +/- 8% at implant. LVEF, NYHA class, and bipolar pacing impedance at the RV outflow tract (RVOT) and apex (RVA) were measured at implant and at 3, 6, 9, and 12 months of follow-up. At implant, impedance was similar in RVOT (548 +/- 115 Omega) and RVA (571 +/- 174 Omega). Between implant and 3 months, mean impedance decreased (P < 0.0001) at both the RVOT (472 +/- 62 Omega) and RVA (488 +/- 86 Omega), LVEF increased (43 +/- 14%, P < 0.0001), and the NYHA class decreased from 2.4 +/- 0.5 to 2.1 +/- 0.6 (P = 0.0001). Changes in RVA impedance correlated with changes in LVEF (r = 0.45, P = 0.002). A 50 Omega decrease in RVA impedance corresponded to a 3% decrease in LVEF. RVA impedance decreased significantly as NYHA class increased from I to IV (P = 0.04). There was no correlation between impedance measured at the RVOT and LVEF or NYHA class. A decrease in bipolar pacing impedance at the RVA was associated with worsening LVEF and the NYHA class. The use of pacing impedance to monitor the clinical status in CHF is dependent on the RV pacing site.

Entities:  

Mesh:

Year:  2005        PMID: 15683525     DOI: 10.1111/j.1540-8159.2005.00028.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.

Authors:  Stefan Sack; Christian Michael Wende; Herbert Nägele; Amos Katz; Wolfgang Rudolf Bauer; Craig Scott Barr; Klaus Malinowski; Harald Schwacke; Francisco Leyva; Jochen Proff; Sergey Berdyshev; Vincent Paul
Journal:  Eur J Heart Fail       Date:  2011-09       Impact factor: 15.534

2.  Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions.

Authors:  Massimo Zecchin; Francesco Solimene; Antonio D'Onofrio; Gabriele Zanotto; Saverio Iacopino; Carlo Pignalberi; Valeria Calvi; Giampiero Maglia; Paolo Della Bella; Fabio Quartieri; Antonio Curnis; Mauro Biffi; Alessandro Capucci; Fabrizio Caravati; Gaetano Senatore; Matteo Santamaria; Fabio Lissoni; Michele Manzo; Massimiliano Marini; Massimo Giammaria; Antonio Rapacciuolo; Gianfranco Sinagra; Daniele Giacopelli; Alessio Gargaro; Ennio C Pisanò
Journal:  J Arrhythm       Date:  2020-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.